2′, 3′-cyclic nucleotide 3′-phosphodiesterase: a novel candidate autoantigen in demyelinating diseases M Rösener, PA Muraro, A Riethmüller, M Kalbus, G Sappler, ... Journal of neuroimmunology 75 (1-2), 28-34, 1997 | 44 | 1997 |
A functional basis for the association of HLA class II genes adn susceptibility to multiple sclerosis: cellular immune responses to myelin basic protein in a multiplex family RR Voskuhl, R Martin, HF McFarland Journal of neuroimmunology 42 (2), 199-207, 1993 | 24 | 1993 |
A gene pathway analysis highlights the role of cellular adhesion molecules in multiple sclerosis susceptibility V Damotte, L Guillot-Noel, NA Patsopoulos, L Madireddy, M El Behi, ... Genes & Immunity 15 (2), 126-132, 2014 | 36 | 2014 |
A molecular view of multiple sclerosis and experimental autoimmune encephalitis: what can we learn from the epitope data? K Vaughan, B Peters, KC O'Connor, R Martin, A Sette Journal of neuroimmunology 267 (1-2), 73-85, 2014 | 22 | 2014 |
A multiple sclerosis–associated variant of CBLB links genetic risk with type I IFN function KH Stürner, U Borgmeyer, C Schulze, O Pless, R Martin The Journal of Immunology 193 (9), 4439-4447, 2014 | 32 | 2014 |
A myelin basic protein peptide is recognized by cytotoxic T cells in the context of four HLA-DR types associated with multiple sclerosis. R Martin, MD Howell, D Jaraquemada, M Flerlage, J Richert, S Brostoff, ... The Journal of experimental medicine 173 (1), 19-24, 1991 | 356 | 1991 |
A novel population of CD4+ CD56+ myelin-reactive T cells lyses target cells expressing CD56/neural cell adhesion molecule. M Vergelli, H Le, JM Van Noort, S Dhib-Jalbut, H McFarland, R Martin Journal of immunology (Baltimore, Md.: 1950) 157 (2), 679-688, 1996 | 72 | 1996 |
A plea for “Omics” research in complex diseases such as multiple sclerosis—a change of mind is needed R Martin, D Leppert Journal of the neurological sciences 222 (1), 3-5, 2004 | 12 | 2004 |
A powerful combination: the use of positional scanning libraries and biometrical analysis to identify cross-reactive T cell epitopes JJ Nino-Vasquez, G Allicotti, E Borras, DB Wilson, D Valmori, R Simon, ... Molecular immunology 40 (14-15), 1063-1074, 2004 | 72 | 2004 |
A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper R Saccardi, MS Freedman, MP Sormani, H Atkins, D Farge, LM Griffith, ... Multiple Sclerosis Journal 18 (6), 825-834, 2012 | 100 | 2012 |
A standardised frankincense extract reduces disease activity in relapsing-remitting multiple sclerosis (the SABA phase IIa trial) KH Stürner, JP Stellmann, J Dörr, F Paul, T Friede, S Schammler, ... Journal of Neurology, Neurosurgery & Psychiatry 89 (4), 330-338, 2018 | 23 | 2018 |
A systems biology approach uncovers cell-specific gene regulatory effects of genetic associations in multiple sclerosis Nature communications 10 (1), 2236, 2019 | 66 | 2019 |
A truncation variant of the cation channel P2RX5 is upregulated during T cell activation P Abramowski, C Ogrodowczyk, R Martin, O Pongs PLoS One 9 (9), e104692, 2014 | 25 | 2014 |
A type I interferon signature in monocytes is associated with poor response to interferon-β in multiple sclerosis M Comabella, JD Lünemann, J Rio, A Sanchez, C Lopez, E Julia, ... Brain 132 (12), 3353-3365, 2009 | 233 | 2009 |
Advisory Board NeuroproMiSe A Compston, VK Kuchroo, R Martin, H Wekerle, HL Weiner Max-Planck Institute, 0 | | |
Alpha crystallin B: EBNA1 antibody cross-reactivity and T cell responses in multiple sclerosis O Thomas, M Bronge, K Tengvall, B Akpinar, O Nilsson, E Holmgren, ... MULTIPLE SCLEROSIS JOURNAL 29, 482-483, 2023 | | 2023 |
Alterations of Thymus-Derived Tregs in Multiple Sclerosis T Lorenzini, W Faigle, J Ruder, MJ Docampo, L Opitz, R Martin Neurology: Neuroimmunology & Neuroinflammation 11 (4), e200251, 2024 | | 2024 |
Altered CSF albumin quotient links peripheral inflammation and brain damage in MS M Puthenparampil, P Tomas-Ojer, T Hornemann, A Lutterotti, I Jelcic, ... Neurology: Neuroimmunology & Neuroinflammation 8 (2), e951, 2021 | 20 | 2021 |
An altered peptide ligand antagonizes antigen-specific T cells of patients with human T lymphotropic virus type I-associated neurological disease R Kubota, SS Soldan, R Martin, S Jacobson The Journal of Immunology 164 (10), 5192-5198, 2000 | 21 | 2000 |
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis International IBD Genetics Consortium (IIBDGC), C Agliardi, L Alfredsson, ... Nature genetics 45 (11), 1353-1360, 2013 | 1344 | 2013 |